問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taipei Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2022-02-04 - 2025-06-13
Condition/Disease
Test Drug
Participate Sites3Sites
Recruiting3Sites
2021-10-01 - 2027-12-31
Participate Sites8Sites
Recruiting8Sites
2021-11-01 - 2025-12-31
Participate Sites9Sites
Recruiting9Sites
2013-10-01 - 2025-04-01
Participate Sites7Sites
Terminated7Sites
2024-03-01 - 2027-05-31
Participate Sites4Sites
Recruiting4Sites
2020-08-01 - 2025-04-07
Terminated8Sites
2021-05-21 - 2024-06-30
Cervical Cancer
Tisotumab Vedotin
Recruiting1Sites
Terminated2Sites
2021-10-22 - 2023-07-14
Participate Sites5Sites
Recruiting5Sites
2019-01-01 - 2023-09-30
Advanced/metastatic malignancies, and preferred indications: head and neck squamous cell carcinoma (HNSCC), non-small cell lung cancer (NSCLC),hepatocellular carcinoma (HCC), esophageal cancer, gastric cancer, melanoma,renal cell cancer, pancreatic cancer, cervical cancer, and triple negative breastcancer (BC)
KY1044
Not yet recruiting4Sites
Recruiting2Sites
Terminated1Sites
2022-05-02 - 2023-04-18
全部
